Description

2-Phenyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine is a heterocyclic organic compound featuring a fused imidazopyridine core, which serves as a critical pharmacophore and synthetic intermediate. This compound matters for its role as a versatile building block in medicinal chemistry, enabling the development of novel therapeutic agents targeting a range of biological pathways. Pharmaceutical research and development organizations need this high-purity intermediate for the synthesis of potential drug candidates, particularly in central nervous system (CNS) and oncology research.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of bioactive molecules and active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used as a core scaffold for designing and optimizing new chemical entities in drug discovery programs.
• Ligand and Probe Development: Employed in creating chemical probes to study biological targets and enzyme functions.
• Chemical Biology: Serves as a building block for constructing compound libraries used in high-throughput screening.
• Academic Research: Utilized in universities and research institutes for studying heterocyclic chemistry and reaction mechanisms.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical development from discovery to early-phase clinical trials.

Basic Information

Product Name	2-Phenyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine
CAS No.	944897-33-0
Molecular Formula	C₁₄H₁₅N₃
Molecular Weight	225.29 g/mol
Synonyms	2-Phenyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine; 3H-Imidazo[4,5-c]pyridine, 4,5,6,7-tetrahydro-2-phenyl-; 2-Phenyl-4,5,6,7-tetrahydroimidazo[4,5-c]pyridine; 2-Phenyl-1,4,5,6,7,8-hexahydroimidazo[4,5-c]pyridine; Imidazo[4,5-c]pyridine, 4,5,6,7-tetrahydro-2-phenyl-; 944897-33-0 (CAS)
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. For this advanced intermediate, we implement a multi-tiered QC protocol that includes identity confirmation, purity assessment, and impurity profiling. Certificates of Analysis (COA) are provided with each batch, detailing results from analytical methods such as HPLC, NMR, and mass spectrometry. We support development under cGMP guidelines where required for pre-clinical and clinical-stage materials.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, containers should be kept tightly sealed and consideration given to storage under an inert atmosphere for long-term stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.